APA (7th ed.) Citation

Schwandt, M. L., Cortes, C. R., Kwako, L. E., George, D. T., Momenan, R., Sinha, R., . . . Heilig, M. (2016). The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects. Neuropsychopharmacology (New York, N.Y.), 41(12), 2818-2829. https://doi.org/10.1038/npp.2016.61

Chicago Style (17th ed.) Citation

Schwandt, Melanie L., et al. "The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But Not of Anti-Craving Effects." Neuropsychopharmacology (New York, N.Y.) 41, no. 12 (2016): 2818-2829. https://doi.org/10.1038/npp.2016.61.

MLA (9th ed.) Citation

Schwandt, Melanie L., et al. "The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But Not of Anti-Craving Effects." Neuropsychopharmacology (New York, N.Y.), vol. 41, no. 12, 2016, pp. 2818-2829, https://doi.org/10.1038/npp.2016.61.